Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer's disease

Based on earlier work by several groups, in 1989 Selkoe and colleagues [1,2] suggested that amyloid beta (A beta) found in cerebral blood vessels, skin tissue, and elsewhere might come from a peripheral source and might contribute to the Alzheimer's disease (AD) pathogenesis. Independently, using four clinical series and four different types of controls, Sobel et al. [3,4] found that having a primary occupation likely to have resulted in medium-to-high extremely low frequency (ELF) electromagnetic field (EMF) exposure significantly increases the risk of AD. The means by which EMF (or any other) exposure might precipitate the Alzheimer pathogenesis are currently unknown. One possibility is that EMF exposure might affect the peripheral or neuronal processing of the amyloid precursor protein. We outlined a cascade of events as a hypothesis of how EMF exposure may be associated with AD onset. In two published papers, Sobel et al. [3,4] found elevated risk of AD associated with having a primary occupation likely to have resulted in medium-to-high EMF exposure. The four clinical series examined were widely separated by time or distance and the data were collected without any consideration of EMF exposure. (Table 1) provides information about patients and control subjects and the ascertainment period for each series. The total number of AD patients in the four series was 713 and the total number of control subjects was 627. Surrogate-derived data were used for all patients and for control subjects from Finnish Series 1 and the Rancho Los Amigos Medical Center (RLAMC), Los Angeles, series because these subjects were demented. Following standard practice, we defined high EMF exposure as averaging above 10 milligauss (mG) or often above 100 mG and medium EMF exposure as averaging between 2 and 10 mG or often above 10 mG. We classified all other EMF exposures as low. The …

[1]  K. Foetisch,et al.  Complete cDNA sequence of human lysosome-associated membrane protein-2. , 1994, Biochemical and biophysical research communications.

[2]  H. Soininen,et al.  Amyloid β-protein deposition in skin of patients with dementia , 1992, The Lancet.

[3]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[4]  R. Taussig,et al.  Mammalian Membrane-bound Adenylyl Cyclases (*) , 1995, The Journal of Biological Chemistry.

[5]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[6]  T. Budinger,et al.  Pulsed magnetic field effects on calcium signaling in lymphocytes: Dependence on cell status and field intensity , 1992, FEBS letters.

[7]  Y. Hamnerius,et al.  Ca2+ ion transport through patch-clamped cells exposed to magnetic fields. , 1995, Bioelectromagnetics.

[8]  T. Wisniewski,et al.  Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. , 1994, Biochemical and biophysical research communications.

[9]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[10]  R. Fletterick,et al.  Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[12]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[13]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele ϵ4 with late‐onset Alzheimer's disease among Finnish centenarians , 1995, Neurology.

[14]  M. Reale,et al.  A role for Ca2+ in the effect of very low frequency electromagnetic field on the blastogenesis of human lymphocytes , 1985, FEBS letters.

[15]  G. Reynolds.  Banbury Report 15, Biological Aspects of Alzheimer's Disease: edited by R. Katzman, Cold Spring Harbor Laboratory, 1983. US $55.00 ($66.00 outside US) (xiv + 495 pages) ISBN 0 87969 213 8 , 1984 .

[16]  A. Liboff,et al.  Nifedipine is an antagonist to cyclotron resonance enhancement of 45Ca incorporation in human lymphocytes. , 1987, Cell calcium.

[17]  W. R. Adey,et al.  Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Penn,et al.  Neurosurgical horizons in Parkinson's disease , 1993, Neurology.

[19]  D. Selkoe.  Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease , 1989, Neurobiology of Aging.

[20]  V. Lednev,et al.  Possible mechanism for the influence of weak magnetic fields on biological systems. , 1991, Bioelectromagnetics.

[21]  W. R. Adey,et al.  Ionic factors in release of 45Ca2+ from chicken cerebral tissue by electromagnetic fields. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Michael E. Johnson,et al.  Proposed cation‐π mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognition , 1995, FEBS letters.

[23]  K. H. Mild,et al.  Intracellular calcium oscillations in a T-cell line after exposure to extremely-low-frequency magnetic fields with variable frequencies and flux densities. , 1995, Bioelectromagnetics.

[24]  F. Kaiser,et al.  Model for external influences on cellular signal transduction pathways including cytosolic calcium oscillations. , 1995, Bioelectromagnetics.

[25]  A. Oseroff,et al.  Rapid-flow resonance Raman spectroscopy of photolabile molecules: rhodopsin and isorhodopsin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Greengard,et al.  Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. R. Adey,et al.  Calcium uptake by leukemic and normal T-lymphocytes exposed to low frequency magnetic fields. , 1991, Bioelectromagnetics.

[29]  J. García-Sancho,et al.  Effects of extremely-low-frequency electromagnetic fields on ion transport in several mammalian cells. , 1994, Bioelectromagnetics.

[30]  Erik Lundgren,et al.  Intracellular calcium oscillations induced in a T‐cell line by a weak 50 Hz magnetic field , 1993, Journal of cellular physiology.

[31]  D. Selkoe.  Altered structural proteins in plaques and tangles: What do they tell us about the biology of Alzheimer's disease? , 1986, Neurobiology of Aging.

[32]  K. H. Mild,et al.  CD45 phosphatase in Jurkat cells is necessary for response to applied ELF magnetic fields , 1995, FEBS letters.

[33]  L. S. Kinney,et al.  Effects of ELF fields on calcium-ion efflux from brain tissue in vitro. , 1982, Radiation research.

[34]  Electromagnetic modulation of biological processes , 1983 .

[35]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[36]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[37]  C. Masters,et al.  Proteolytic Processing of Alzheimer's Disease βA4 Amyloid Precursor Protein in Human Platelets (*) , 1995, The Journal of Biological Chemistry.

[38]  S. Ferrari,et al.  Effect of Low-Frequency Low-Energy Pulsing Electromagnetic Fields on the Response to Lectin Stimulation of Human Normal and Chronic Lymphocytic Leukemia Lymphocytes , 1985 .

[39]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Little,et al.  Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. , 1991, Brain research. Molecular brain research.

[41]  R. Liburdy,et al.  Time‐varying and static magnetic fields act in combination to alter calcium signal transduction in the lymphocyte , 1992, FEBS letters.

[42]  Acceptance speech on the occasion of receiving the d'Arsonval Medal. , 1994, Bioelectromagnetics.

[43]  Pekka J Jarvinen,et al.  Public health implications , 2006 .

[44]  D. Selkoe,et al.  Calcium ionophore increases amyloid beta peptide production by cultured cells. , 1994, Biochemistry.

[45]  T. Wisniewski,et al.  Apolipoprotein E : binding to soluble Alzheimer's β-amyloid , 1993 .

[46]  C. Masters,et al.  Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. , 1994, Blood.

[47]  Bradley T. Hyman,et al.  Reduced apolipoprotein ϵ4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals , 1994, Neurology.